Independent biomarker of SLE progression. Regulates the expression of the YTH N6-methyladenosine RNA-binding protein 2YTHDF2 by down-regulating TNFAIP3 and the NF-κB pathway. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.